← FDA Drug Approvals (Drugs@FDA)

RYTARY

NDA · New Drug Application · Sponsor: IMPAX · Approved 2015-01-07

Drug application

FDA Application #

NDA203312

Application type

New Drug Application

Brand name

RYTARY

Generic name

CARBIDOPA AND LEVODOPA

Active ingredients

CARBIDOPA; LEVODOPA

Dosage form

CAPSULE, EXTENDED RELEASE

Route

ORAL

Marketing status

Prescription

Sponsor

IMPAX

Manufacturer

Zydus Pharmaceuticals USA Inc.

First approval

2015-01-07

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown